Kevin Boehnke's guest appearances

Kevin Boehnke

Sigma Nutrition Radio

Psychedelic Science for the People

Abel James

Dave Feldman

Dean Dwyer

Jason Fung

Michael Ruscio

James Clear

Ian Dunican

Carol Tavris

Megan Rossi

Robb Wolf

Stephan Guyenet

Chris Masterjohn

John Berardi

Gary Taubes

Andy Galpin

OwlTail

Oregon became the first state to decriminalize psilocybin in 2020 and many other states are expected to follow suit. Dr. Kevin Boehnke, a Research Investigator in the Department of Anesthesiology at the University of Michigan, shares his research on the therapeutic uses of cannabis for chronic pain and discusses his latest paper, “Applying Lessons from Cannabis to the Psychedelic Highway.”  As we look back on this past decade of cannabis legalization, what can we learn and how can we avoid repeating the same mistakes? We talk about whether the Western medical system is ready for psychedelics and he shares ideas for developing safety-oriented policies, collecting data systematically, and making this medicine accessible.  Leave us a review on Apple Podcasts* to win free CBD products from Millie! *(I say iTunes but I mean Apple Podcasts!) Here is how: https://agriculturalgenomics.org/podcast/How-to-Leave-a-Review.pdf Dr. Boehnke’s Article: “Applying Lessons From Cannabis to the Psychedelic Highway” https://pubmed.ncbi.nlm.nih.gov/36219016/ NYT Article: “Taking the Magic out of Magic Mushrooms”: https://www.nytimes.com/2022/07/15/opinion/hallucinations-psychedelics-depression.html

Oregon became the first state to decriminalize psilocybin in 2020 and many other states are expected to follow suit. Dr. Kevin Boehnke, a Research Investigator in the Department of Anesthesiology at the University of Michigan, shares his research on the therapeutic uses of cannabis for chronic pain and discusses his latest paper, “Applying Lessons from Cannabis to the Psychedelic Highway.”  As we look back on this past decade of cannabis legalization, what can we learn and how can we avoid repeating the same mistakes? We talk about whether the Western medical system is ready for psychedelics and he shares ideas for developing safety-oriented policies, collecting data systematically, and making this medicine accessible.  Leave us a review on Apple Podcasts* to win free CBD products from Millie! *(I say iTunes but I mean Apple Podcasts!) Here is how: <a href="https://agriculturalgenomics.org/podcast/How-to-Leave-a-Review.pdf" rel="nofollow" target="_blank">https://agriculturalgenomics.org/podcast/How-to-Leave-a-Review.pdf</a> Dr. Boehnke’s Article: “Applying Lessons From Cannabis to the Psychedelic Highway” <a href="https://pubmed.ncbi.nlm.nih.gov/36219016/" rel="nofollow" target="_blank">https://pubmed.ncbi.nlm.nih.gov/36219016/</a> NYT Article: “Taking the Magic out of Magic Mushrooms”: <a href="https://www.nytimes.com/2022/07/15/opinion/hallucinations-psychedelics-depression.html" rel="nofollow" target="_blank">https://www.nytimes.com/2022/07/15/opinion/hallucinations-psychedelics-depression.html</a>

#33 Applying Lessons from Cannabis to Psychedelic Liberalization with Dr. Kevin Boehnke

Carrie Cuttler

Kevin Boehnke is a researcher at the University of Michigan, in the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of illicit or semi-licit substances (cannabis, psychedelics). His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization. Carrie Cuttler is an Assistant Professor at Washington State University. Her research at the Health and Cognition Laboratory there focuses on elucidating the potentially beneficial and detrimental effects of chronic cannabis use and acute cannabis intoxication. Her recent work has focused on examining links between cannabis use and mental health (e.g., ADHD, PTSD, OCD, depression, anxiety). Show notes available at sigmanutrition.com/episode420/

Kevin Boehnke is a researcher at the University of Michigan, in the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of illicit or semi-licit substances (cannabis, psychedelics). His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization. Carrie Cuttler is an Assistant Professor at Washington State University. Her research at the Health and Cognition Laboratory there focuses on elucidating the potentially beneficial and detrimental effects of chronic cannabis use and acute cannabis intoxication. Her recent work has focused on examining links between cannabis use and mental health (e.g., ADHD, PTSD, OCD, depression, anxiety). Show notes available at <a href="https://sigmanutrition.com/episode420/" rel="nofollow" target="_blank">sigmanutrition.com/episode420/</a>

#420: Cannabis – Kevin Boehnke, PhD & Carrie Cuttler, PhD